Selpercatinib (LOXO-292) in patients (pts) with RET-altered thyroid cancer

Lori J Wirth, Eric J Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen H Lorch, Francis Worden, Marcia S Brose, Sophie Leboulleux, Yann Godbert, Marie Meurer, John Morris, Taofeek K Owonikoko, Daniel Shao-Weng Tan, Oliver Gautschi, Jyoti Patel, Luxi Yang, Jennifer Kherani, Maria E Cabanillas, Manisha H Shah